News

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments.
See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
BioNTech BNTX 1.61 % increase; green up pointing triangle will acquire all shares of CureVac CVAC 0.93 % increase; green up pointing triangle after the two sides reached an agreement in a deal ...
When Özlem Türeci, co-founder of BioNTech, first heard about the novel coronavirus, she knew her company would have to work on a vaccine to fight it. American Amanda Anisimova upsets No. 1 Aryna ...
Biontech CEO Ugur Sahin said that the Corona vaccine developed by his company could be available by the end of the year, if studies confirm positive data received so far.
Moderna is suing fellow vaccine developers Pfizer and its German partner BioNTech, accusing it of infringing on patents related to mRNA technology used in their COVID-19 vaccine, the company ...
BioNTech will pay OncoC4 $200 million up front and get global rights to its drug. Privately held OncoC4 could earn milestone payments, plus royalties if the research leads to a commercialized product.
BioNTech (22UAy.DE) expects results by September from trials testing the COVID-19 vaccine that it and Pfizer (PFE.N) have developed in babies as young as six months old, German magazine Spiegel ...
BioNTech SE, in collaboration with Genentech, Inc., is conducting a Phase II study titled ‘A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX ...
Shares of BioNTech fell 5.7% on Monday. Vaccine stocks are volatile after Moderna’s updated revenue guidance for 2025, which fell below analyst expectations. Market-moving news hits Benzinga Pro ...
BioNTech is bolstering its artificial intelligence and machine learning capabilities through the £362 million acquisition of InstaDeep, a startup whose technology has already supported the ...